NUEVOCOR
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapyโbased treatments that have the potential to restore cardiac function in diseased hearts.
NUEVOCOR
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2020-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.nuevocor.com
Status:
Active
Total Funding:
24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Nuevocor
EDBI
EDBI investment in Series A - Nuevocor
EVX Ventures
EVX Ventures investment in Series A - Nuevocor
Xora Innovation
Xora Innovation investment in Series A - Nuevocor
Seeds Capital
Seeds Capital investment in Series A - Nuevocor
Official Site Inspections
http://www.nuevocor.com Semrush global rank: 6.26 M Semrush visits lastest month: 1.22 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Nuevocor"
ABOUT US - Nuevocor
Nuevocor is a IND-stage biotech focused on treating genetic cardiomyopathies by addressing their underlying mechanical defects. ... Eminent cell biologist with seminal contributions in โฆSee details»
Nuevocor - Crunchbase Company Profile & Funding
Nuevocor may be growing as it has received research funding, which is a positive indicator of financial support and investment in its preclinical biotech activities. The financial backing is โฆSee details»
Nuevocor - The Org
Nuevocor is a new biotech start-up in Singapore striving to develop gene therapies for genetic cardiomyopathies. It will leverage a deep understanding of cardiac cell biology, as well as a โฆSee details»
Nuevocor - LinkedIn
Nuevocor | 1,487 followers on LinkedIn. Pioneering novel therapies for untreatable cardiac diseases | Nuevocor, with offices in USA and Singapore, is developing genetic medicines for untreatable ...See details»
Nuevocor | Boehringer Ingelheim Venture Fund
Nuevocor is developing innovative therapies for cardiomyopathies using its proprietary PrOSIAโข mechanobiology platform to target the biomechanical root causes of these diseases. The โฆSee details»
CONTACT - Nuevocor
United States. Nuevocor Therapeutics Inc. 500 Office Ctr Drive, Suite 400, Fort Washington, PA 19034See details»
Nuevocor - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Nov 3, 2022: Venture Round - Nuevocor โ obfuscated. obfuscated โ โฆSee details»
Nuevocor - Contacts, Employees, Board Members, Advisors
Organization. Nuevocor . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Nuevocor has 7 current employee profiles, including โฆSee details»
Nuevocor - VentureRadar
Nuevocorโs LMNA gene therapy is based on decades of research into fundamental mechanisms underlying LMNA-associated disease enabled by the development of novel technologies on โฆSee details»
Nuevocor Closes US$45 Million Series B Financing for โฆ
5 days ago Nuevocor is an IND-stage biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology, headquartered in Singapore with an office in the U.S. and ...See details»
Nuevocor - Products, Competitors, Financials, Employees, โฆ
Nuevocor is a biotechnology company focused on the development of genetic medicines for genetic cardiomyopathies. Use the CB Insights Platform to explore Nuevocor's full profile. ...See details»
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the
Jan 24, 2025 Nuevocor is a biotechnology company that is pioneering an innovative pathway-centric approach to developing functional cures for heart conditions known as โฆSee details»
SCIENCE | Nuevocor
United States. Nuevocor Therapeutics Inc. 500 Office Ctr Drive, Suite 400, Fort Washington, PA 19034See details»
Nuevocor โ Startups.Bio
Nuevocor is a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies. The companyโs lead programme is an adeno-associated virus (AAV) โ โฆSee details»
Nuevocor Pte Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
About Nuevocor Nuevocor is a biotechnology company that is pioneering an innovative pathway-centric approach to developing genetic medicines for heart conditions known as โฆSee details»
Angelini Ventures partners & invests - Nobi
Nuevocor is a biotechnology company that is pioneering an innovative pathway-centric approach to developing functional cures for heart conditions known as cardiomyopathies. By harnessing โฆSee details»
Nuevocor Closes US$45 Million Series B Financing for Clinical ...
5 days ago Nuevocor is an IND-stage biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology, ... and management, along with โฆSee details»
PIPELINE | Nuevocor
United States. Nuevocor Therapeutics Inc. 500 Office Ctr Drive, Suite 400, Fort Washington, PA 19034See details»
Nuevocor raises $45M in Series B financing - The Business Journals
4 days ago Nuevocor is developing a one-time gene therapy for heart failure patients. Inovio taking on Covid again, almost 3 years after abandoning vaccine CEO says biotech firm is on โฆSee details»
Singapore-based biotech firm Nuevocor raises US$45 ... - ๅไธๆถๆฅ
4 days ago Nuevocor focuses on developing cures for heart muscle diseases. The new investment will support first-in-human clinical trials for Nuevocorโs NVC-001, a form of gene โฆSee details»